A citation-based method for searching scientific literature

Yundong He, Liguo Wang, Ting Wei, Yu-Tian Xiao, Haoyue Sheng, Hengchuan Su, Daniel P Hollern, Xiaoling Zhang, Jian Ma, Simeng Wen, Hongyan Xie, Yuqian Yan, Yunqian Pan, Xiaonan Hou, Xiaojia Tang, Vera J Suman, Jodi M Carter, Richard Weinshilboum, Liewei Wang, Krishna R Kalari, Saravut J Weroha, Alan H Bryce, Judy C Boughey, Haidong Dong, Charles M Perou, Dingwei Ye, Matthew P Goetz, Shancheng Ren, Haojie Huang. J Clin Invest 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A novel small-molecule MRCK inhibitor blocks cancer cell invasion.
Mathieu Unbekandt, Daniel R Croft, Diane Crighton, Mokdad Mezna, Duncan McArthur, Patricia McConnell, Alexander W Schüttelkopf, Simone Belshaw, Andrew Pannifer, Mairi Sime,[...]. Cell Commun Signal 2014
36
50


Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma.
Hailong Ma, Wenyi Yang, Liming Zhang, Shuli Liu, Mei Zhao, Ge Zhou, Lizhen Wang, Shufang Jin, Zhiyuan Zhang, Jingzhou Hu. Br J Cancer 2019
25
50

Type I interferons in anticancer immunity.
Laurence Zitvogel, Lorenzo Galluzzi, Oliver Kepp, Mark J Smyth, Guido Kroemer. Nat Rev Immunol 2015
529
50

Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis.
Arpita Datta, Shuo Deng, Vennila Gopal, Kenneth Chun-Hong Yap, Clarissa Esmeralda Halim, Mun Leng Lye, Mei Shan Ong, Tuan Zea Tan, Gautam Sethi, Shing Chuan Hooi,[...]. Cancers (Basel) 2021
10
50

Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines.
Francesca Di Modugno, Lucia DeMonte, Michele Balsamo, Giovanna Bronzi, Maria Rita Nicotra, Massimo Alessio, Elke Jager, John S Condeelis, Angela Santoni, Pier Giorgio Natali,[...]. Cancer Res 2007
69
50

Resistance to IFN-alpha-induced apoptosis is linked to a loss of STAT2.
Ana L Romero-Weaver, Hsiang-Wen Wang, Håkan C Steen, Anthony J Scarzello, Veronica L Hall, Faruk Sheikh, Raymond P Donnelly, Ana M Gamero. Mol Cancer Res 2010
32
50

Persistent LCMV infection is controlled by blockade of type I interferon signaling.
John R Teijaro, Cherie Ng, Andrew M Lee, Brian M Sullivan, Kathleen C F Sheehan, Megan Welch, Robert D Schreiber, Juan Carlos de la Torre, Michael B A Oldstone. Science 2013
490
50

Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.
Lijun Sun, Jiaxi Wu, Fenghe Du, Xiang Chen, Zhijian J Chen. Science 2013
50

Modulation of Nod2-dependent NF-kappaB signaling by the actin cytoskeleton.
Sylvie Legrand-Poels, Gaelle Kustermans, Françoise Bex, Elisabeth Kremmer, Thomas A Kufer, Jacques Piette. J Cell Sci 2007
97
50

Characterization of the type I interferon locus and identification of novel genes.
Matthew P Hardy, Catherine M Owczarek, Lars S Jermiin, Mikael Ejdebäck, Paul J Hertzog. Genomics 2004
134
50

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.
Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan, Sarmistha Nanda, Lanfang Qin, Vidyalakshmi Sethunath, Tao Wang,[...]. Clin Cancer Res 2021
7
50

Fascin in Cell Migration: More Than an Actin Bundling Protein.
Maureen C Lamb, Tina L Tootle. Biology (Basel) 2020
7
50

Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis.
Toni Celià-Terrassa, Daniel D Liu, Abrar Choudhury, Xiang Hang, Yong Wei, Jose Zamalloa, Raymundo Alfaro-Aco, Rumela Chakrabarti, Yi-Zhou Jiang, Bong Ihn Koh,[...]. Nat Cell Biol 2017
56
50

NOD proteins: regulators of inflammation in health and disease.
Dana J Philpott, Matthew T Sorbara, Susan J Robertson, Kenneth Croitoru, Stephen E Girardin. Nat Rev Immunol 2014
363
50

Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential.
Yangbo Feng, Philip V LoGrasso, Olivier Defert, Rongshi Li. J Med Chem 2016
170
50

Interferon-stimulated genes: a complex web of host defenses.
William M Schneider, Meike Dittmann Chevillotte, Charles M Rice. Annu Rev Immunol 2014
50




Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors.
Francesca Di Modugno, Pierluigi Iapicca, Aaron Boudreau, Marcella Mottolese, Irene Terrenato, Letizia Perracchio, Russ P Carstens, Angela Santoni, Mina J Bissell, Paola Nisticò. Proc Natl Acad Sci U S A 2012
72
50

The added value of type I interferons to cytotoxic treatments of cancer.
Laura Bracci, Antonella Sistigu, Enrico Proietti, Federica Moschella. Cytokine Growth Factor Rev 2017
12
50



Fascin1 suppresses RIG-I-like receptor signaling and interferon-β production by associating with IκB kinase ϵ (IKKϵ) in colon cancer.
Tomio Matsumura, Shigeaki Hida, Masato Kitazawa, Chifumi Fujii, Akira Kobayashi, Michiko Takeoka, Shun-Ichiro Taniguchi, Shin-Ichi Miyagawa. J Biol Chem 2018
7
50

Battlefield Cytoskeleton: Turning the Tide on Plant Immunity.
Pai Li, Brad Day. Mol Plant Microbe Interact 2019
21
50

Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.
Emilio Bria, Francesca Di Modugno, Isabella Sperduti, Pierluigi Iapicca, Paolo Visca, Gabriele Alessandrini, Barbara Antoniani, Sara Pilotto, Vienna Ludovini, Jacopo Vannucci,[...]. Oncotarget 2014
24
50

Role of NLRs in the Regulation of Type I Interferon Signaling, Host Defense and Tolerance to Inflammation.
Ioannis Kienes, Tanja Weidl, Nora Mirza, Mathias Chamaillard, Thomas A Kufer. Int J Mol Sci 2021
6
50

Penetration resistance: PKR's other talent.
Adam Lacy-Hulbert, Lynda M Stuart. Immunity 2012
1
100


Retinoic acid-induced gene-1 (RIG-I) associates with the actin cytoskeleton via caspase activation and recruitment domain-dependent interactions.
Amitava Mukherjee, Stefanie A Morosky, Le Shen, Christopher R Weber, Jerrold R Turner, Kwang Sik Kim, Tianyi Wang, Carolyn B Coyne. J Biol Chem 2009
40
50

Designed nanomolar small-molecule inhibitors of Ena/VASP EVH1 interaction impair invasion and extravasation of breast cancer cells.
Matthias Barone, Matthias Müller, Slim Chiha, Jiang Ren, Dominik Albat, Arne Soicke, Stephan Dohmen, Marco Klein, Judith Bruns, Maarten van Dinther,[...]. Proc Natl Acad Sci U S A 2020
3
50

Mechanical forces facilitate actin polymerization at focal adhesions in a zyxin-dependent manner.
Hiroaki Hirata, Hitoshi Tatsumi, Masahiro Sokabe. J Cell Sci 2008
157
50

PKR: A Kinase to Remember.
Shunit Gal-Ben-Ari, Iliana Barrera, Marcelo Ehrlich, Kobi Rosenblum. Front Mol Neurosci 2019
64
50

Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade.
Nicolas Jacquelot, Takahiro Yamazaki, Maria P Roberti, Connie P M Duong, Miles C Andrews, Loic Verlingue, Gladys Ferrere, Sonia Becharef, Marie Vétizou, Romain Daillère,[...]. Cell Res 2019
73
50

RIG-I-like receptors: their regulation and roles in RNA sensing.
Jan Rehwinkel, Michaela U Gack. Nat Rev Immunol 2020
185
50

Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy.
Catherine Dold, Carles Rodriguez Urbiola, Guido Wollmann, Lisa Egerer, Alexander Muik, Lydia Bellmann, Heidelinde Fiegl, Christian Marth, Janine Kimpel, Dorothee von Laer. Mol Ther Oncolytics 2016
39
50

NOD1 and NOD2: Beyond Peptidoglycan Sensing.
A Marijke Keestra-Gounder, Renée M Tsolis. Trends Immunol 2017
57
50


Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.
Jesse M Zaretsky, Angel Garcia-Diaz, Daniel S Shin, Helena Escuin-Ordinas, Willy Hugo, Siwen Hu-Lieskovan, Davis Y Torrejon, Gabriel Abril-Rodriguez, Salemiz Sandoval, Lucas Barthly,[...]. N Engl J Med 2016
50

Actin and RIG-I/MAVS signaling components translocate to mitochondria upon influenza A virus infection of human primary macrophages.
Tiina Ohman, Johanna Rintahaka, Nisse Kalkkinen, Sampsa Matikainen, Tuula A Nyman. J Immunol 2009
70
50

Linking actin dynamics and gene transcription to drive cellular motile functions.
Eric N Olson, Alfred Nordheim. Nat Rev Mol Cell Biol 2010
636
50

Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7.
M Sato, N Hata, M Asagiri, T Nakaya, T Taniguchi, N Tanaka. FEBS Lett 1998
424
50

The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells.
Zhiqiang Zhang, Bin Yuan, Musheng Bao, Ning Lu, Taeil Kim, Yong-Jun Liu. Nat Immunol 2011
544
50

Regulation of actin dynamics by protein kinase R control of gelsolin enforces basal innate immune defense.
Aaron T Irving, Die Wang, Oliver Vasilevski, Olivier Latchoumanin, Noga Kozer, Andrew H A Clayton, Anette Szczepny, Hiroyuki Morimoto, Dakang Xu, Bryan R G Williams,[...]. Immunity 2012
33
50

Mitochondria in innate immune signaling.
Balaji Banoth, Suzanne L Cassel. Transl Res 2018
96
50

Actin dynamics, architecture, and mechanics in cell motility.
Laurent Blanchoin, Rajaa Boujemaa-Paterski, Cécile Sykes, Julie Plastino. Physiol Rev 2014
611
50

Multifunctional roles of gelsolin in health and diseases.
Guo Hua Li, Pamela D Arora, Yu Chen, Christopher A McCulloch, Peter Liu. Med Res Rev 2012
158
50

RNase L interacts with Filamin A to regulate actin dynamics and barrier function for viral entry.
Krishnamurthy Malathi, Mohammad Adnan Siddiqui, Shubham Dayal, Merna Naji, Heather J Ezelle, Chun Zeng, Aimin Zhou, Bret A Hassel. mBio 2014
14
50

hMENA(11a) contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells.
P Trono, F Di Modugno, R Circo, S Spada, A Di Benedetto, R Melchionna, B Palermo, S Matteoni, S Soddu, M Mottolese,[...]. Oncogene 2016
10
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.